Introduction {#sec1-1753425919872818}
============

Sepsis is considered to be a complicated clinical syndrome arising from systemic inflammatory reactions to bacteria or bacterial products.^[@bibr1-1753425919872818]^ Although there has been great improvement in antibiotic therapy and life support, the global death rate of sepsis patients remains up to 30--60%.^[@bibr2-1753425919872818]^ Therefore, predictive markers to identify high-risk populations are urgently needed for early detection and preventive care. Cytokines are critically involved in modulation of host immune response, while changed cytokine levels have been shown to participate in sepsis development.^[@bibr3-1753425919872818]^ Delineating the variation in gene expression and associated differences in responses to sepsis might facilitate in exploiting new genetically tailored diagnostic and therapeutic interventions, which could improve outcome in patients with sepsis susceptibility.

IL-6 is a vital inflammatory cytokine generated by various cells, such as leucocytes, endothelial cells, myocytes, adipocytes and fibroblasts.^[@bibr4-1753425919872818]^ IL-6 plays a significant role in the immune response and regulation of inflammation reactions. High IL-6 levels have been demonstrated to be related to the elevated risk and death rate of severe sepsis.^[@bibr5-1753425919872818]^ The IL-6 gene, located on 7p21 and spanning 5 kb, contains four introns and five exons. There have been several identified polymorphisms in the IL-6 gene promoter region. Among these, the common -174G/C polymorphism (rs1800795) contains a DNA-binding site for nuclear factor IL-6, a transcription factor which can interact with estradiol receptor complexes to regulate IL-6 gene expression.^[@bibr6-1753425919872818]^ The -572G/C polymorphism (rs1800796) does not contain any potent homology to any identified transcription factor-binding site, with a close location to glucocorticoid response elements.^[@bibr7-1753425919872818]^ To date, there have been much research evaluating the association of IL-6 polymorphisms with sepsis, albeit with inconsistent findings.

Meta-analysis is a useful method to summarise the different articles. It not only overcomes the drawbacks of small sample size and inadequate statistical power of genetic studies with complicated characteristics, but also provides more convincing conclusions compared to a single study.^[@bibr8-1753425919872818]^ Thus, in this research study, a meta-analysis was conducted by enrolling eligible studies to assess the relationship between IL-6-174G/C and -572G/C polymorphisms and sepsis.

Materials and methods {#sec2-1753425919872818}
=====================

Literature search {#sec3-1753425919872818}
-----------------

We thoroughly searched the online electronic databases (PubMed, EMBASE and CNKI) using the following search terms: (interleukin-6 or IL-6) and (polymorphism or variant or variation) and ('sepsis'). In addition, we manually searched the references of original studies and reviews on this topic. There was no restriction on language.

Criteria for inclusion and exclusion {#sec4-1753425919872818}
------------------------------------

Eligible studies were enrolled if they met the following criteria: (a) case-control studies, (b) only cases with definitive diagnosis of sepsis and (c) evaluation of IL-6 polymorphisms and sepsis. Exclusion criteria were: (a) abstracts, reviews and duplication of studies; (b) not case-control studies; and (c) absence of genotype frequency.

Data extraction {#sec5-1753425919872818}
---------------

The following information was extracted from every article by two independent authors: year of publication, first author, ethnicity, numbers as well as genotype numbers of cases and controls, with evidence of Hardy--Weinberg equilibrium (HWE) in controls. Discrepancies were resolved by discussion.

Statistical analysis {#sec6-1753425919872818}
--------------------

Stata v12.0 (Stata Corp., College Station, TX) was used for statistical analysis. ORs with corresponding 95% CIs was used to assess the correlation of IL-6 gene polymorphisms (-174G/C and -572G/C) with sepsis under A versus a, homozygote (AA vs. aa), heterozygote comparison (AA vs. Aa) and dominant model and recessive model between groups. To be specific, the dominant model referred to as Aa + aa versus AA, where 'A' and 'a' represented major and minor alleles, respectively, and the recessive model was aa versus AA + Aa.^[@bibr9-1753425919872818]^ Moreover, the variation caused by heterogeneity was estimated by calculating the inconsistency index I^2^, with I^2^ values of 25%, 25--75% and 75% representing low, moderate or high degrees of inconsistency, respectively.^[@bibr10-1753425919872818]^ When the heterogeneity was absent (I^2^ \< 50%), a fixed-effects model was used to calculate the combined OR estimates for every study; otherwise, a random-effects model was applied. Additionally, sensitivity analysis was conducted by limiting the meta-analysis to research conforming to HWE. Finally, possible publication bias was visually determined by Begg's funnel plots.^[@bibr11-1753425919872818]^

Results {#sec7-1753425919872818}
=======

Characteristics of included studies {#sec8-1753425919872818}
-----------------------------------

The study selection process is shown in [Figure 1](#fig1-1753425919872818){ref-type="fig"}. According to the inclusion criteria, 16 qualified case-control studies were finally enrolled,^[@bibr12-1753425919872818][@bibr13-1753425919872818][@bibr14-1753425919872818][@bibr15-1753425919872818][@bibr16-1753425919872818][@bibr17-1753425919872818][@bibr18-1753425919872818][@bibr19-1753425919872818][@bibr20-1753425919872818][@bibr21-1753425919872818][@bibr22-1753425919872818][@bibr23-1753425919872818][@bibr24-1753425919872818][@bibr25-1753425919872818][@bibr26-1753425919872818]--[@bibr27-1753425919872818]^ all of which assessed the correlation of IL-6 polymorphisms with sepsis risk. All studies were published in English. Fifteen articles studied the -174G/C polymorphism and four studied the -572C/G polymorphism. For -174G/C, there were 11 studies with Caucasian subjects, two with Asian populations, two with African populations and one with a mixed population. Eight studies were performed in adults, six in neonates and two in paediatric populations. For -572C/G, there were two studies with Caucasian subjects and two with Asian populations. Three studies were conducted in adults and one in paediatric populations. The major features of enrolled studies are summarised in [Table 1](#table1-1753425919872818){ref-type="table"}.

![Flow diagram for selection of publication.](10.1177_1753425919872818-fig1){#fig1-1753425919872818}

###### 

Study selection and subject characteristics of included studies in meta-analysis.

![](10.1177_1753425919872818-table1)

  Author            Yr     Ethnicity   Age         Cases   Controls   Genotypes for cases   Genotypes for controls   Genotypes for cases   Genotypes for controls   *P* for HWE                                 
  ----------------- ------ ----------- ----------- ------- ---------- --------------------- ------------------------ --------------------- ------------------------ ------------- ----- ----- ----- ----- ----- ------
  -174G/C                                                                                                                                                                                                       
   Schluter         2002   Caucasian   Adult       50      276        51                    49                       313                   239                      13            25    12    91    131   54    0.58
   Treszl           2003   Caucasian   Neonatal    33      70         49                    17                       97                    43                       18            13    2     34    29    7     0.82
   Balding          2003   Caucasian   Adult       183     389        215                   151                      371                   241                      59            97    27    97    177   32    0.00
   Ahrens           2004   Caucasian   Neonatal    50      306        69                    31                       57                    309                      24            21    5     3     51    129   0.42
   Sipahi           2006   Caucasian   Pediatric   44      77         66                    22                       123                   31                       26            14    4     52    19    6     0.04
   Gopel            2006   Caucasian   Neonatal    97      320        108                   86                       399                   241                      29            50    18    128   143   49    0.39
   Baier \#1        2006   African     Neonatal    114     119        206                   22                       229                   9                        94            18    2     110   9     0     0.67
   Baier \#2        2006   Caucasian   Neonatal    31      26         40                    22                       30                    22                       12            16    3     7     16    3     0.01
   Michalek         2007   Caucasian   Pediatric   409     644        477                   341                      665                   623                      127           223   59    160   345   139   0.07
   Abdel-Hady       2009   African     Neonatal    54      71         60                    48                       88                    54                       17            26    11    28    32    11    0.71
   Davis            2010   Caucasian   Adult       23      52         31                    15                       64                    40                       10            11    2     21    22    9     0.44
   Carregaro        2010   Mix         Adult       97      207        137                   57                       284                   130                      49            39    9     94    96    17    0.27
   Shimada          2011   Asian       Adult       123     102        246                   0                        204                   0                        123           0     0     102   0     0     0.00
   Martin-Loeches   2012   Caucasian   Adult       1227    953        1678                  776                      1289                  617                      581           516   130   438   413   102   0.75
   Panayides        2015   Caucasian   Adult       185     108        303                   67                       184                   32                       123           57    5     79    26    3     0.63
   Mao              2016   Asian       Adult       188     162        149                   227                      182                   142                      56            37    95    68    46    48    0.00
  -572C/G                                                                                                                                                                                                       
   Michalek         2007   Caucasian   Pediatric   409     644        51                    767                      56                    1228                     7             37    365   2     52    588   0.46
   Gu               2008   Asian       Adult       54      321        26                    82                       153                   489                      5             16    33    16    121   184   0.49
   Shimada          2011   Asian       Adult       123     102        53                    191                      41                    163                      3             47    72    2     37    63    0.19
   Panayides        2015   Caucasian   Adult       198     115        49                    347                      49                    181                      6             37    155   6     37    72    0.66

Meta-analysis results {#sec9-1753425919872818}
---------------------

The major outcomes of the meta-analysis of the IL-6-174G/C polymorphism and sepsis risk are presented in [Figure 2](#fig2-1753425919872818){ref-type="fig"} and [Table 2](#table2-1753425919872818){ref-type="table"}. Overall, the -174G/C polymorphism was not significantly associated with sepsis risk (C vs. G: OR = 1.04, 95% CI = 0.79--1.38; CC vs. GG: OR = 0.86, 95% CI = 0.53--1.41; CG vs. GG: OR = 0.99, 95% CI = 0.79--1.24; dominant model: OR = 0.97, 95% CI = 0.74--1.29; recessive model: OR = 0.92, 95% CI = 0.61--1.39). In subgroup analysis stratified by ethnicity, a significant association was detected in Asians and Africans but not in Caucasians. In subgroup analysis by age,-174G/C was insignificantly related to sepsis risk in adults, neonates and paediatric populations. On subgroup analysis stratified by HWE, eight papers in Caucasians were included with HWE studies, and the analyses on their cumulative data indicate that the IL-6-174G/C polymorphism is not associated with sepsis risk (C vs. G: OR = 1.35, 95% CI = 0.89--2.03; CC vs. GG: OR = 0.53, 95% CI = 0.25--1.12; CG vs. GG: OR = 0.93, 95% CI = 0.65--1.31; dominant model: OR = 0.77, 95% CI = 0.50--1.18; recessive model: OR = 0.62, 95% CI = 0.35--1.09). In addition, sensitivity analysis was conducted through omitting HWE studies. Non-HWE studies changed the final results, implicating the existence of publication bias in results due to non-HWE studies. The major findings of the IL-6-572C/G polymorphism and sepsis risk are listed in [Figure 3](#fig3-1753425919872818){ref-type="fig"} and [Table 3](#table3-1753425919872818){ref-type="table"}. Combined results revealed that the IL-6-572C/G polymorphism was not related to sepsis susceptibility (G vs. C: OR = 0.98, 95% CI = 0.79--1.22; GG vs. CC: OR = 1.46, 95% CI = 0.53--4.03; GC vs. CC: OR = 0.82, 95% CI = 0.54--1.27; dominant model: OR = 0.88, 95% CI = 0.55--1.41; recessive model: OR = 1.55, 95% CI = 0.82--2.92). On subgroup analysis stratified by ethnicity, the IL-6-572C/G polymorphism was not statistically associated with sepsis risk in Asians or other ethnic groups. When patients were stratified according to age, this polymorphism was not related to sepsis risk in adults.

![Forest plot of OR for association between the IL-6-174G/C polymorphism and sepsis under the dominant model.](10.1177_1753425919872818-fig2){#fig2-1753425919872818}

###### 

Summary ORs and 95% CIs of IL-6-174G/C polymorphism and sepsis risk.

![](10.1177_1753425919872818-table2)

                          C vs. G             CC vs. GG           GC vs. GG           Dominant model      Recessive model
  ------------------ ---- ------------------- ------------------- ------------------- ------------------- -------------------
  Total              16   1.04 (0.79--1.38)   0.86 (0.53--1.41)   0.99 (0.79--1.24)   0.97 (0.74--1.29)   0.92 (0.61--1.39)
  Ethnicity                                                                                               
   Asian             2    0.51 (0.38--0.69)   2.40 (1.46--3.94)   0.94 (0.72--1.24)   1.71 (1.10--2.65)   2.43 (1.56--3.77)
   Caucasian         11   1.22 (0.91--1.63)   0.66 (0.37--1.19)   0.97 (0.52--1.80)   0.84 (0.60--1.17)   0.74 (0.46--1.18)
   African           2    0.61 (0.40--0.93)   1.96 (0.76--5.10)   1.75 (0.98--3.11)   1.87 (1.08--3.25)   1.63 (0.69--3.87)
  Age                                                                                                     
   Adult             8    0.87 (0.69--1.09)   1.21 (0.98--1.50)   0.97 (0.84--1.11)   1.02 (0.89--1.16)   1.31 (0.91--1.88)
   Neonate           6    1.29 (0.48--3.46)   0.50 (0.08--3.04)   0.79 (0.35--1.80)   0.66 (0.23--1.88)   0.66 (0.18--2.51)
   Children          2    1.08 (0.65--1.81)   0.57 (0.40--0.83)   0.87 (0.66--1.14)   0.93 (0.50--1.75)   0.64 (0.46--0.88)
  HWE                                                                                                     
   Yes               11   1.15 (0.82--1.61)   0.70 (0.38--1.28)   1.00 (0.75--1.34)   0.90 (0.63--1.28)   0.75 (0.46--1.21)
   No                5    0.78 (0.52--1.17)   1.79 (1.25--2.57)   0.95 (0.71--1.28)   1.22 (0.93--1.58)   1.88 (1.36--2.60)
   Caucasian (yes)   8    1.35 (0.89--2.03)   0.53 (0.25--1.12)   0.93 (0.65--1.31)   0.77 (0.50--1.18)   0.62 (0.35--1.09)
   Caucasian (no)    3    0.93 (0.74--1.17)   1.28 (0.76--2.18)   0.94 (0.67--1.34)   1.00 (0.72--1.40)   1.38 (0.85--2.24)

HWE: Hardy--Weinberg equilibrium.

![Forest plot of OR for association between the IL-6-572G/C polymorphism and sepsis under the dominant model.](10.1177_1753425919872818-fig3){#fig3-1753425919872818}

###### 

Summary ORs and 95% CIs of IL-6-572C/G polymorphism and sepsis risk.

![](10.1177_1753425919872818-table3)

                    G vs. C             GG vs. CC            GC vs. CC           Dominant model      Recessive model
  ------------- --- ------------------- -------------------- ------------------- ------------------- --------------------
  Total         4   0.98 (0.79--1.22)   1.46 (0.53--4.03)    0.82 (0.54--1.27)   0.88 (0.55--1.41)   1.55 (0.82--2.92)
  Ethnicity                                                                                          
   Asian        2   1.06 (0.76--1.47)   1.61 (0.63--4.08)    0.93 (0.62--1.41)   0.99 (0.67--1.47)   1.71 (0.68--4.32)
   Caucasian    2   0.88 (0.32--2.40)   1.53 (0.13--17.95)   0.74 (0.31--1.79)   0.79 (0.29--2.18)   1.67 (0.18--15.81)
  Age                                                                                                
   Adult        3   0.83 (0.52--1.34)   0.98 (0.47--2.06)    0.72 (0.43--1.22)   0.76 (0.44--1.29)   1.10 (0.53--2.28)
   Paediatric   1   /                   /                    /                   /                   /

Publication bias {#sec10-1753425919872818}
----------------

Begg's funnel plots were conducted to evaluate the publication bias of enrolled articles. There was no obvious asymmetry in the allele model in consideration of the shapes of funnel plots in all genetic models, implying the low publication bias in our meta-analysis ([Figures 4](#fig4-1753425919872818){ref-type="fig"} and [5](#fig5-1753425919872818){ref-type="fig"}).

![Begg's funnel plot for association between the IL-6-174G/C polymorphism and sepsis.](10.1177_1753425919872818-fig4){#fig4-1753425919872818}

![Begg's funnel plot for association between the IL-6-572G/C polymorphism and sepsis.](10.1177_1753425919872818-fig5){#fig5-1753425919872818}

Discussion {#sec11-1753425919872818}
==========

Sepsis is characterised as a systemic inflammatory response due to infection. A central event in the pathophysiological cascade of sepsis is excessive systemic release of pro-inflammatory cytokines such as IL-6 in response to microbial invasion. IL-6 is a multifunctional cytokine regulating immune reactions and is regarded as an endogenous pyrogen that induces fever in patients with infections. The -174G/C and -572C/G polymorphisms in the IL-6 gene have been found to be related to IL-6 promoter activity, resulting in interindividual alterations in cytokine levels.^[@bibr28-1753425919872818]^ In various genetic studies, IL-6 polymorphisms in the promoter region have been shown to increase the risk for sepsis, albeit with inconsistent results. Different ethnicities, insufficient power and the small effect of the polymorphism on sepsis risk make it even more complicated to interpret these studies. In consideration of the elevated numbers of studies in recent years, there is a need to reconcile these data.

In this meta-analysis, we systemically examined the correlation of IL-6 gene polymorphisms (-174G/C and -572C/G) with sepsis susceptibility. As a result, the IL-6 gene -174G/C polymorphism was not statistically associated with sepsis risk. In subgroup analysis stratified by nationality, this polymorphism was related to sepsis in Asians and Africans but not in Caucasians. On the one hand, only two articles on Asians and Africans were analysed, and the number of studies and samples were relatively small. On the other hand, two included studies for Asian ethnicity were not in HWE equilibrium. However, the included studies report very limited information to provide any detailed insight into these potential problems. Well-designed studies with more subjects will be required for further validation of these results. In subgroup analysis stratified by age, this polymorphism was not significantly correlated to sepsis risk in adult, neonatal or paediatric populations. Sensitivity analysis was conducted by omitting HWE studies for the total population and Caucasian ethnicity. Non-HWE studies changed the outcomes, implicating that our results had a publication bias due to non-HWE studies. For the IL-6-572C/G polymorphism, there was no significant relationship of this genotype with sepsis risk, which was still insignificant in subsequent subgroup analyses stratified by ethnicity or age. As with other diseases, the pathogenesis of sepsis is caused by synergistic interaction of several genes and gene environments, and these interactions require further investigation in future studies.

There are certain limitations in the study. First, the majority of included research only studied the correlation of IL-6 polymorphisms with sepsis risk, while there is inaccessibility of more accurate adjusted ORs for other covariates (including family history, age, environmental factors and infectious condition). Second, the incomplete raw data and publication limitations led to a failure to enrol all relevant studies in the present meta-analysis. Third, we failed to investigate the genetic--environmental interplays due to multiple testing and inadequate studies. Indeed, it is probable that certain lifestyle and environmental factors (such as smoking) could affect the relationship of gene polymorphisms with sepsis risk.

Taken together, we demonstrated that the IL-6-174G/C polymorphism may contribute to sepsis risk in Africans and Asians. No significant association was observed between the IL-6-572G/C polymorphism and sepsis risk. Further evaluation of the influence of gene polymorphisms on sepsis will require well-designed studies with large sample sizes.
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